Diagnostic performance of a commercial immunoblot assay for myositis antibody testing

Pathology

Volumn 48, Issue 4, 2016, Pages 363-366

  Bundell, Chris ^a,b   Rojana udomsart, Arada ^b,c   Mastaglia, Frank ^d   Hollingsworth, Peter ^a,b   McLean Tooke, Andrew ^a  

^a PATHWEST LABORATORY MEDICINE   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c Yala Hospital   (Thailand)

^d MURDOCH UNIVERSITY   (Australia)

Author keywords

Autoantibodies; dermatomyositis; diagnosis; immunoblot; myositis; polymyositis

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; EJ ANTIGEN; JO 1 ANTIBODY; KU ANTIGEN; MI 2 ANTIGEN; MYOSITIS ASSOCIATED AUTOANTIBODY; MYOSITIS SPECIFIC AUTOANTIBODY; OJ ANTIGEN; PL7 ANTIGEN; PMSCL100 ANTIGEN; PMSCL75 ANTIGEN; RO52 ANTIGEN; SIGNAL RECOGNITION PARTICLE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DERMATOMYOSITIS; HUMAN; IMMUNOBLOTTING; INCLUSION BODY MYOSITIS; MAJOR CLINICAL STUDY; MYOSITIS; REFERENCE VALUE; EVALUATION STUDY; IMMUNOLOGY; PROCEDURES;

AUTOANTIBODIES; HUMANS; IMMUNOBLOTTING; MYOSITIS;

EID: 84978756701     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.1016/j.pathol.2016.03.012     Document Type: Article

References (18)

1. 1 Luo, Y.B., Mastaglia, F.L., Dermatomyositis, polymyositis and immune-mediated necrotising myopathies. Biochim Biophys Acta 1852 (2015), 622–632.
2. 2 Dalakas, M.C., Immunotherapy of myositis: issues, concerns and future prospects. Nat Rev Rheumatol 6 (2010), 129–137.
3. 3 Targoff, I.N., Autoantibodies and their significance in myositis. Curr Rheumatol Rep 10 (2008), 333–340.
4. 4 Tansley, S.L., McHugh, N.J., Myositis specific and associated autoantibodies in the diagnosis and management of juvenile and adult idiopathic inflammatory myopathies. Curr Rheumatol Rep, 16, 2014, 464.
5. 5 Lega, J.C., Fabien, N., Reynaud, Q., et al. The clinical phenotype associated with myositis-specific and associated autoantibodies: a meta-analysis revisiting the so-called antisynthetase syndrome. Autoimmun Rev 13 (2014), 883–891.
6. 6 Graf, S.W., Hakendorf, P., Lester, S., et al. South Australian Scleroderma Register: autoantibodies as predictive biomarkers of phenotype and outcome. Int J Rheum Dis 15 (2012), 102–109.
7. 7 Sordet, C., Goetz, J., Sibilia, J., Contribution of autoantibodies to the diagnosis and nosology of inflammatory muscle disease. Joint Bone Spine 73 (2006), 646–654.
8. 8 Tansley, S.L., Betteridge, Z.E., McHugh, N.J., The diagnostic utility of autoantibodies in adult and juvenile myositis. Curr Opin Rheumatol 25 (2013), 772–777.
9. 9 Hoogendijk, J.E., Amato, A.A., Lecky, B.R., et al. 119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10-12 October 2003, Naarden, The Netherlands. Neuromuscul Disord 14 (2004), 337–345.
10. 10 Needham, M., Mastaglia, F.L., Inclusion body myositis: current pathogenetic concepts and diagnostic and therapeutic approaches. Lancet Neurol 6 (2007), 620–631.
11. 11 Welborn, T.A., (eds.) The Busselton Study: Mapping Population Health (Cardiovascular and Respiratory Disease Risk Factors in Busselton, Australia, 1998, Australian Medical Publishing Co, North Sydney.
12. 12 Ghirardello, A., Bendo, R., Rampudda, M.E., et al. Commercial blot assays in the diagnosis of systemic rheumatic diseases. Autoimmun Rev 8 (2009), 645–649.
13. 13 Hanke, K., Brückner, C.S., Dähnrich, C., et al. Antibodies against PM/Scl-75 and PM/Scl-100 are independent markers for different subsets of systemic sclerosis patients. Arthritis Res Ther, 11, 2009, R22.
14. 14 Brouwer, R., Hengstman, G.J., Vree Egberts, W., et al. Autoantibody profiles in the sera of European patients with myositis. Ann Rheum Dis 60 (2001), 116–123.
15. 15 Ronnelid, J., Barbasso Helmers, S., Storfors, H., et al. Use of a commercial line blot assay as a screening test for autoantibodies in inflammatory myopathies. Autoimmun Rev 9 (2009), 58–61.
16. 16 Koenig, M., Fritzler, M.J., Targoff, I.N., Troyanov, Y., Senécal, J.L., Heterogeneity of autoantibodies in 100 patients with autoimmune myositis: insights into clinical features and outcomes. Arthritis Res Ther, 9, 2007, R78.
17. 17 Cruellas, M.G., Viana Vdos, S., Levy-Neto, M., Souza, F.H., Shinjo, S.K., Myositis-specific and myositis-associated autoantibody profiles and their clinical associations in a large series of patients with polymyositis and dermatomyositis. Clinics (Sao Paulo) 68 (2013), 909–914.
18. 18 Ellis, E., Ann Tan, J., Lester, S., et al. Necrotizing myopathy: clinicoserologic associations. Muscle Nerve 45 (2012), 189–194.